1. Home >
  2. Companies >
  3. Acquired >
  4. Life Science >
  5. Austria >
  6. AFFiRiS - Specific Active Immunotherapy anti-alpha-synuclein Programs

AFFiRiS - Specific Active Immunotherapy anti-alpha-synuclein Programs Overview

Life ScienceCompany

Where is AFFiRiS - Specific Active Immunotherapy anti-alpha-synuclein Programs headquartered?

AFFiRiS - Specific Active Immunotherapy anti-alpha-synuclein Programs is headquartered in Vienna, Austria.

What sector is AFFiRiS - Specific Active Immunotherapy anti-alpha-synuclein Programs in?

AFFiRiS - Specific Active Immunotherapy anti-alpha-synuclein Programs is a life science company.

AFFiRiS - Specific Active Immunotherapy (SAIT) anti-alpha-synuclein Programs

Vienna, 1030
Austria,

AFFiRiS' Specific Active Immunotherapy (SAIT) anti-alpha-synuclein Programs are clinically validated active vaccine candidates for the treatment of Parkinson's disease. AFFiRiS' Specific Active Immunotherapy (SAIT) anti-alpha-synuclein Programs is based in Vienna, Austria.


Company Summary

SECTOR

Life Science


Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for AFFiRiS - Specific Active Immunotherapy anti-alpha-synuclein Programs

Life Science Companies , Austria Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for Austria Companies

Largest Austria Companies , Acquisitive Austria Companies , Recently Acquired Austria Companies , Recently Sold Austria Companies , Private Austria Companies , Public Austria Companies , Acquired Austria Companies , PE Backed Austria Companies
Mergr

Solution for

Product

Company

Legal